However, survivors exhibited a greater mean decrease in chemerin (42.7 ± 22.2 μg/L vs. 13.2 ± 11.3 μg/L, p < 0.001), and a greater percentage change from baseline (Δchemerin% 13.8 ± 5.1% vs. 3.1 ± 2.4%, p < 0.001) compared to nonsurvivors The Kaplan–Meier survival curves showed that patients with lower circulating chemerin at sepsis onset presented improved survival, with the cutoff value of chemerin being 392.5 μg/L (Figure 6A). This evidence concerns the gene RARRES2 and Sepsis.